Daniel Dubé
Daniel Dubé publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Receptor Mechanisms and Signaling, Phosphodiesterase function and regulation and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #1,487,558 of 7,710,434 ranked researchers
- Rank in Canada
- #50,060 of 183,316
- Works
- 60
- Citations
- 2.2k
- Citations per work
- 36.3
What does Daniel Dubé research?
Daniel Dubé's work is mostly in Chemistry (25%), Biochemistry, Genetics and Molecular Biology (20%), Medicine (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1932.3%
- Physical Sciences1729.1%
- Chemistry1524.7%
- Computer Science34.4%
- Life Sciences1423.4%
- Health Sciences915.2%
- Medicine915.2%
- 1Organic Chemistry25% of their works
- 2Molecular Biology20% of their works
- 3Pharmacology11% of their works
- 4Computer Vision and Pattern Recognition4% of their works
- 5Cardiology and Cardiovascular Medicine4% of their works
- 6Pharmacology4% of their works
Research topics
- Receptor Mechanisms and Signaling
- Phosphodiesterase function and regulation
- Cholinesterase and Neurodegenerative Diseases
- Renin-Angiotensin System Studies
- Inflammatory mediators and NSAID effects
- Chemical synthesis and alkaloids
- Asymmetric Synthesis and Catalysis
- Traditional and Medicinal Uses of Annonaceae
Which keywords describe Daniel Dubé's research?
The keywords of their largest research topics: Pharmacology, Crystal Structure, G-Protein-Coupled Receptors, Inflammation, cAMP Signaling, Cyclic Nucleotide Phosphodiesterases, Acetylcholinesterase and Cholinesterase Inhibitors.
- Acetogenins
- Enantioselective Reactions
- Alkaloids
- Cyclooxygenase-2 Inhibitors
- Angiotensin
- Cholinesterase Inhibitors
- cAMP Signaling
- Inflammation
- Crystal Structure
- Pharmacology
- G-Protein-Coupled Receptors
- Cyclic Nucleotide Phosphodiesterases
- Acetylcholinesterase
- Synthesis
- Cancer
- Renin
- Amaryllidaceae
- Organocatalysis
- Annonaceae
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Pharmacology212 topics
- Crystal Structure121 topic
- G-Protein-Coupled Receptors121 topic
- Inflammation122 topics
- Cyclic Nucleotide Phosphodiesterases101 topic
- cAMP Signaling101 topic
- Acetylcholinesterase91 topic
- Cholinesterase Inhibitors91 topic
- Synthesis92 topics
- Angiotensin61 topic
- Cancer61 topic
- Cyclooxygenase-2 Inhibitors61 topic
- Renin61 topic
- Alkaloids51 topic
- Amaryllidaceae51 topic
- Enantioselective Reactions51 topic
- Organocatalysis51 topic
- Acetogenins41 topic
- Annonaceae41 topic
Where does Daniel Dubé work?
Daniel Dubé's main affiliation in the publication record is Merck Canada Inc. (Canada), Canada.
How many publications and citations does Daniel Dubé have?
OpenAlex counts 60 works and 2,180 citations for Daniel Dubé, an h-index of 23, ranking #1,487,558 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel Dubé. Posts are plain text and can be reported.